Page last updated: 2024-10-24

carmustine and Lymphocytosis

carmustine has been researched along with Lymphocytosis in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Lymphocytosis: Excess of normal lymphocytes in the blood or in any effusion.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laport, GG1
Levine, BL1
Stadtmauer, EA1
Schuster, SJ1
Luger, SM1
Grupp, S1
Bunin, N1
Strobl, FJ1
Cotte, J1
Zheng, Z1
Gregson, B1
Rivers, P1
Vonderheide, RH1
Liebowitz, DN1
Porter, DL1
June, CH1
Icli, F1
Ezdinli, EZ1
Costello, W1
Berard, CW1
Bennett, JM1
Carbone, PP1

Trials

1 trial available for carmustine and Lymphocytosis

ArticleYear
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation.
    Blood, 2003, Sep-15, Volume: 102, Issue:6

    Topics: Adolescent; Adoptive Transfer; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Pro

2003

Other Studies

1 other study available for carmustine and Lymphocytosis

ArticleYear
Diffuse well-differentiated lymphocytic lymphoma (DLWD): response and survival.
    Cancer, 1978, Volume: 42, Issue:4

    Topics: Aged; Antineoplastic Agents; Carmustine; Cell Differentiation; Chlorambucil; Cyclophosphamide; Drug

1978